Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Corrects Over 700 Points; Banking and Pharma Stocks Under Pressure
Wed, 28 Jul 11:30 am

Share markets in India have extended early losses and are presently trading deep in the red.

Weak global cues dampened investor sentiment.

Global stock markets fell as the sell-off in Chinese tech stocks on Beijing's regulatory crackdown triggered concerns about whether this will have an impact on global economies.

Asian share markets have fallen for three consecutive sessions as regulatory crackdowns in China roiled stocks in the technology, property and education sectors.

Putting more pressure, the International Monetary Fund (IMF) on Tuesday maintained its 6% global growth forecast for 2021, upgrading its outlook for the US but cutting estimates for developing countries struggling with surging Covid-19 infections.

The BSE Sensex fell over 700 points, or 1.2% to 51,800 levels. Meanwhile, the NSE Nifty fell to 15,500-mark.

Presently, the BSE Sensex is trading down by 506 points, down 0.9%. Meanwhile, the NSE Nifty is trading down by 154 points.

The sell-off is seen particularly in the banking, finance and pharma sector that pushed benchmark indices lower.

Shares of Dr Reddy's Lab and Axis Bank fell over 2.6%, while HDFC Bank and M&M fell 2%.

Broader markets also cooled down after the recent runup. Both, the BSE Mid cap index and the BSE Small cap index fell 1%.

Market participants will keep track of the Fed's policy statement due later today, followed by a news conference by Chairman Jerome Powell.

In one of his videos for Fast Profits Daily, India's #1 trader, Vijay Bhambwani talks about why the markets have been showing some signs of weakness for a while.

What has caused the correction and could it get bigger? What are the key things you need to watch out for?

Vijay answers this question in the video.

You can watch the video here: Should We Worry About Tuesdays Fall?

More details to follow in the upcoming commentary.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex Corrects Over 700 Points; Banking and Pharma Stocks Under Pressure". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.